Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Simulations Plus Inc
(NQ:
SLP
)
36.83
+0.35 (+0.96%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Simulations Plus Inc
< Previous
1
2
3
4
5
6
7
Next >
Simulations Plus Reports Third Quarter Fiscal 2022 Financial Results
July 06, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Stock Scores Composite Rating Move Up To 96
July 06, 2022
The IBD SmartSelect Composite Rating for Simulations Plus stock rose from 94 to 96 Wednesday. The medical software stock has 94 RS Rating.
Via
Investor's Business Daily
Earnings Scheduled For July 6, 2022
July 06, 2022
Companies Reporting After The Bell • Saratoga Investment (NYSE:SAR) is expected to report quarterly earnings at $0.53 per share on revenue of $19.21 million.
Via
Benzinga
Kornit Digital, Simulations Plus And 3 Stocks To Watch Heading Into Wednesday
July 06, 2022
With the US stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Preview: Simulations Plus's Earnings
July 05, 2022
Simulations Plus (NASDAQ:SLP) is set to give its latest quarterly earnings report on Wednesday, 2022-07-06. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Can Simulations Plus Stock Maintain Its Impressive Growth?
April 15, 2022
Simulations Plus, Inc. held up well in the company’s recently released financial results.
Via
Talk Markets
Simulations Plus Hosts 2nd Annual Pharmacometrics Workshop
June 30, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Jim Cramer Recommends This Mining Company And 5 Other Stocks
June 29, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said AT&T Inc (NYSE: T) is a "distinct hold. If it were $18, it’s a buy. If it was $23, it’s a sell."
Via
Benzinga
Simulations Plus Collaborates with Multinational Pharmaceutical Company to Provide Modeling & Simulation Support for COVID-19 Treatment
June 23, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Sets Date for Third Quarter Fiscal Year 2022 Earnings Release and Conference Call
June 21, 2022
From
Simulations Plus, Inc.
Via
Business Wire
DILIsym Software Publication Outlines Impact on the CGRP Field for Migraine
June 16, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Privia Health Stock Among The Few That've Risen This Month
June 13, 2022
Privia Health is trying to complete a cup without handle with a 29.07 entry. See if it clears the breakout price in above average volume.
Via
Investor's Business Daily
Simulations Plus Releases ADMET Predictor Version 10.4 (X.4)
May 26, 2022
From
Simulations Plus, Inc.
Via
Business Wire
U.S. FDA Renews Annual DILIsym Software Licenses for 2022
May 05, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Successfully Delivers FDA-Funded Project
April 28, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Enters New Collaboration to Advance DDDPlus™ Software
April 21, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus to Present at the Berenberg Discover AI Seminar
April 19, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus: Q2 Earnings Insights
April 07, 2022
Simulations Plus (NASDAQ:SLP) reported its Q2 earnings results on Wednesday, April 6, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Simulations Plus Reports Second Quarter Fiscal 2022 Financial Results
April 06, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Earnings Preview For Simulations Plus
April 05, 2022
Simulations Plus (NASDAQ:SLP) is set to give its latest quarterly earnings report on Wednesday, 2022-04-06. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference
March 24, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software
March 29, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Sets Date for Second Quarter Fiscal Year 2022 Earnings Release and Conference Call
March 22, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit National Organization for Rare Disorders
March 17, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 08, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Partners with Large Pharmaceutical Company to Drive Advancements to the GastroPlus Mechanistic Oral Absorption Model
January 20, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus Enters New Collaboration with Leading Animal Health Company
January 13, 2022
From
Simulations Plus, Inc.
Via
Business Wire
Simulations Plus to Present at Sidoti Winter Small Cap Investor Conference
January 12, 2022
From
Simulations Plus, Inc.
Via
Business Wire
33 Stocks Moving In Friday's Mid-Day Session
January 07, 2022
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 35.9% to $4.6899 after the company announced an integration with Amazon Ads' demand-side platform. Absci...
Via
Benzinga
56 Biggest Movers From Friday
January 10, 2022
Gainers Hour Loop, Inc. (NASDAQ: HOUR) shares jumped 99.8% to $7.99 after the company priced its IPO at $4 per share. China HGS Real Estate Inc. (NASDAQ: HGSH) shares...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.